Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Indust/Producer Dur Alphadex First Trust | FXR | 2. avr 2025 | 71.10 | +1.44 |
Industrial Logistics Properties Trust | ILPT | 2. avr 2025 | 3.46 | -1.42 |
Industrial Select Sector SPDR | XLI | 2. avr 2025 | 133.05 | +0.94 |
Industrials ETF Vanguard | VIS | 2. avr 2025 | 251.85 | +1.07 |
InflaRx N.V | IFRX | 2. avr 2025 | 1.15 | +9.52 |
Inflection Point Acquisition II | IPXX | 2. avr 2025 | 10.79 | 0.00 |
Inflection Point Acquisition II Unit | IPXXU | 2. avr 2025 | 10.57 | 0.00 |
Infobird | IFBD | 2. avr 2025 | 1.48 | -1.33 |
Informatica | INFA | 2. avr 2025 | 17.75 | +0.57 |
Information Services Group | III | 2. avr 2025 | 4.02 | +2.29 |
Information Technology ETF Vanguard | VGT | 2. avr 2025 | 551.44 | +0.82 |
Infosys ADR | INFY | 2. avr 2025 | 18.39 | +1.04 |
InfuSystems | INFU | 2. avr 2025 | 5.32 | -0.75 |
ING Group ADR | ING | 2. avr 2025 | 19.77 | +0.76 |
Ingersoll Rand | IR | 2. avr 2025 | 81.70 | +1.35 |
Ingevity | NGVT | 2. avr 2025 | 39.54 | +1.78 |
Ingles Markets A | IMKTA | 2. avr 2025 | 65.64 | +0.75 |
Ingram Micro Holding Corp | INGM | 2. avr 2025 | 18.28 | +2.81 |
Ingredion | INGR | 2. avr 2025 | 135.32 | -0.47 |
Inhibikase Therapeutics | IKT | 2. avr 2025 | 2.18 | +4.31 |
Inhibrx Biosciences | INBX | 2. avr 2025 | 14.10 | +0.36 |
INLIF | INLF | 2. avr 2025 | 1.61 | 0.00 |
InMed Pharmaceuticals | INM | 2. avr 2025 | 2.08 | -0.24 |
InMode | INMD | 2. avr 2025 | 17.98 | -0.66 |
INmune Bio | INMB | 2. avr 2025 | 8.07 | +6.32 |
Innate Pharma ADR | IPHA | 2. avr 2025 | 1.79 | -6.28 |
Inno Holdings | INHD | 2. avr 2025 | 4.86 | +0.41 |
Innodata | INOD | 2. avr 2025 | 37.85 | +3.59 |
Innospec | IOSP | 2. avr 2025 | 95.65 | +1.17 |
InnovAge | INNV | 2. avr 2025 | 2.96 | -0.67 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.